Genmab A/S (LON:0MGB)
London
· Delayed Price · Currency is GBP · Price in DKK 1,587.50
+47.50 (3.08%)
At close: Feb 20, 2025
Genmab Market Cap
Genmab has a market cap or net worth of 11.15 billion as of February 21, 2025. Its market cap has decreased by -23.34% in one year.
Market Cap
11.15B
Enterprise Value
8.92B
Revenue
2.39B
Ranking
n/a
PE Ratio
12.82
Stock Price
1,587.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 287.00M to 11.15B, an increase of 3,784.27%. That is a compound annual growth rate of 16.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| Shell | 161.28B |
| HSBC Holdings | 157.51B |
| Unilever | 110.61B |
| Rio Tinto Group | 86.77B |
| RELX PLC | 72.31B |
| BP p.l.c. | 70.06B |
| British American Tobacco p.l.c. | 65.18B |